drugset / Trial / NCT05389176
Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia
RandomizedParallel-groupDouble-blindTreatment
Summary
A sigle-center, randomized controlled trial will be do to investigate the effects of esomol on heart rate, clinical parameters, mortality, and safety in septic shock patients with tachycardia at different stages, compared with patients who received conventional therapy.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2024-03-31
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esmolol | Other / unclassified | — | — |